GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jianzhijia Pharmaceutical Chain Group Co Ltd (SHSE:605266) » Definitions » Piotroski F-Score

Jianzhijia Pharmaceutical Chain Group Co (SHSE:605266) Piotroski F-Score : 6 (As of May. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jianzhijia Pharmaceutical Chain Group Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Jianzhijia Pharmaceutical Chain Group Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score or its related term are showing as below:

SHSE:605266' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 7
Current: 6

During the past 10 years, the highest Piotroski F-Score of Jianzhijia Pharmaceutical Chain Group Co was 7. The lowest was 4. And the median was 6.


Jianzhijia Pharmaceutical Chain Group Co Piotroski F-Score Historical Data

The historical data trend for Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianzhijia Pharmaceutical Chain Group Co Piotroski F-Score Chart

Jianzhijia Pharmaceutical Chain Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A 7.00 6.00 6.00 4.00

Jianzhijia Pharmaceutical Chain Group Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 7.00 5.00 4.00 6.00

Competitive Comparison of Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score

For the Pharmaceutical Retailers subindustry, Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 81.787 + 120.347 + 135.974 + 52.26 = ¥390 Mil.
Cash Flow from Operations was 219.602 + 156.855 + 315.468 + 101.194 = ¥793 Mil.
Revenue was 2170.851 + 2161.861 + 2581.111 + 2313.982 = ¥9,228 Mil.
Gross Profit was 803.199 + 821.934 + 926.096 + 795.196 = ¥3,346 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(9460.635 + 9215.19 + 9419.857 + 9948.935 + 10055.747) / 5 = ¥9620.0728 Mil.
Total Assets at the begining of this year (Mar23) was ¥9,461 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,982 Mil.
Total Current Assets was ¥4,039 Mil.
Total Current Liabilities was ¥4,879 Mil.
Net Income was 59.102 + 105.626 + 178.251 + 76.304 = ¥419 Mil.

Revenue was 1555.909 + 1702.769 + 2805.483 + 2166.874 = ¥8,231 Mil.
Gross Profit was 596.171 + 639.487 + 994.118 + 706.693 = ¥2,936 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(6091.39 + 6706.635 + 8809.136 + 9644.477 + 9460.635) / 5 = ¥8142.4546 Mil.
Total Assets at the begining of last year (Mar22) was ¥6,091 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2,038 Mil.
Total Current Assets was ¥3,785 Mil.
Total Current Liabilities was ¥4,084 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Jianzhijia Pharmaceutical Chain Group Co's current Net Income (TTM) was 390. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Jianzhijia Pharmaceutical Chain Group Co's current Cash Flow from Operations (TTM) was 793. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=390.368/9460.635
=0.04126235

ROA (Last Year)=Net Income/Total Assets (Mar22)
=419.283/6091.39
=0.06883207

Jianzhijia Pharmaceutical Chain Group Co's return on assets of this year was 0.04126235. Jianzhijia Pharmaceutical Chain Group Co's return on assets of last year was 0.06883207. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Jianzhijia Pharmaceutical Chain Group Co's current Net Income (TTM) was 390. Jianzhijia Pharmaceutical Chain Group Co's current Cash Flow from Operations (TTM) was 793. ==> 793 > 390 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=1982.058/9620.0728
=0.20603358

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=2037.584/8142.4546
=0.25024198

Jianzhijia Pharmaceutical Chain Group Co's gearing of this year was 0.20603358. Jianzhijia Pharmaceutical Chain Group Co's gearing of last year was 0.25024198. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=4038.567/4879.354
=0.82768477

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=3784.861/4083.617
=0.92684035

Jianzhijia Pharmaceutical Chain Group Co's current ratio of this year was 0.82768477. Jianzhijia Pharmaceutical Chain Group Co's current ratio of last year was 0.92684035. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Jianzhijia Pharmaceutical Chain Group Co's number of shares in issue this year was 127.462. Jianzhijia Pharmaceutical Chain Group Co's number of shares in issue last year was 129.329. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=3346.425/9227.805
=0.36264583

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2936.469/8231.035
=0.35675574

Jianzhijia Pharmaceutical Chain Group Co's gross margin of this year was 0.36264583. Jianzhijia Pharmaceutical Chain Group Co's gross margin of last year was 0.35675574. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=9227.805/9460.635
=0.9753896

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=8231.035/6091.39
=1.35125727

Jianzhijia Pharmaceutical Chain Group Co's asset turnover of this year was 0.9753896. Jianzhijia Pharmaceutical Chain Group Co's asset turnover of last year was 1.35125727. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Jianzhijia Pharmaceutical Chain Group Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Jianzhijia Pharmaceutical Chain Group Co  (SHSE:605266) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Jianzhijia Pharmaceutical Chain Group Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Jianzhijia Pharmaceutical Chain Group Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Jianzhijia Pharmaceutical Chain Group Co (SHSE:605266) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Qiying Street, Union Street, Panlong District, Yunnan Province, Kunming, CHN, 650224
Jianzhijia Pharmaceutical Chain Group Co Ltd is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
Executives
Jin Yu Mei Supervisors
Chai Zhi Qi senior management
Shi Yan Chun senior management
Hu Yu Ming senior management
Fang Li Supervisors
Sun Li Supervisors
Jiang Yan Yin senior management
Li Heng Director
Zhang Yun Hong Director
Wang Yan Ping Director
Lan Bo Directors, senior managers
Yan Wen senior management

Jianzhijia Pharmaceutical Chain Group Co (SHSE:605266) Headlines

No Headlines